Evidence map›Paper›PMID 39350425›Full record

ReviewCurrent protein & peptide science2025

Chitosan-Peptide Composites for Tissue Engineering Applications: Advances in Treatment Strategies.

Swati Gupta Sanjaykumar, Rishabha Malviya, Saurabh Srivastava, Irfan Ahmad, Prerna Uniyal, Bhupinder Singh, Nazima Nisar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current protein & peptide science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Swati Gupta SanjaykumarDepartment of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, U.P., India.
Rishabha MalviyaDepartment of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, U.P., India.ORCID 0000-0003-2874-6149
Saurabh SrivastavaSchool of Pharmacy, KPJ Healthcare University College, Nilai, Malaysia.
Irfan AhmadDepartment of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia.
Prerna UniyalSchool of Pharmacy, Graphic Era Hill University, Dehradun, India.
Bhupinder SinghDepartment of Law, Sharda University, Greater Noida, U.P., India.
Nazima NisarDepartment of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia.

Funding

Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia R.G.P.2/510/45
6 · The paper itself

Abstract

One of the most well-known instances of an interdisciplinary subject is tissue engineering, where experts from many backgrounds collaborate to address important health issues and improve people's quality of life. Many researchers are interested in using chitosan and its derivatives as an alternative to fabricating scaffold engineering and skin grafts in tissue because of its natural abundance, affordability, biodegradability, biocompatibility, and wound healing properties. Nanomaterials based on peptides can provide cells with the essential biological cues required to promote cellular adhesion and are easily fabricated. Due to such worthy properties of chitosan and peptide, they find their application in tissue engineering and regeneration processes. The implementation of hybrids of chitosan and peptide is increasing in the field of tissue engineering and scaffolding for improved cellular adherence and bioactivity. This review covers the individual applications of peptide and chitosan in tissue engineering and further discusses the role of their conjugates in the same. Here, the recent findings are also discussed, along with studies involving the use of these hybrids in tissue engineering applications.

Indexed as

Biocompatible MaterialsChitosanPeptidesTissue EngineeringAnimalsCell AdhesionHumansTissue ScaffoldsWound HealingBiocompatible MaterialsChitosanPeptidesbiopolymer.Chitosanpeptidescaffoldingtissue engineeringtissue regeneration

Identifiers

PMID39350425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.